Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Completed 2Withdrawn 1Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Lymphoid 1

Conditions

Thyroid Nodule 2Breast Neoplasms 2Thyroid Neoplasms 1Recurrence 1Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroma 1Neuralgia 1Lymphoma, Follicular 1Liver Metastasis Colon Cancer 1Lipoma 1Klatskin Tumor 1Kidney Neoplasms 1Hypesthesia 1Esophageal Neoplasms 1Cicatrix 1Carcinoma, Hepatocellular 1Bone Cancer Metastatic 1Bile Duct Neoplasms 1Agnosia 1Adrenocortical Adenoma 1Adenoma, Islet Cell 1

Interventions

Fulvestrant 58Trastuzumab 49Capecitabine 48Letrozole 45pembrolizumab 41Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37pertuzumab 36abemaciclib 36Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Docetaxel 27Surveys and Questionnaires 26Anastrozole 25exemestane 24Tamoxifen 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Radiofrequency Ablation × Clear all
NCT07206121 2026-02-11

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

Innoblative Designs, Inc.

Phase NA Recruiting
10 enrolled
BreastLymphoid

Breast Neoplasms, Lymphoma, Follicular

NCT04698252 2022-08-08

LARA

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting
74 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡